Cadrenal Therapeutics, Inc. Common Stock (CVKD)
USD 12.96
(13.19%)
USD 12.96
(13.19%)
| Breakdown | 2023 | 2022 |
|---|---|---|
| Revenue | - | - |
| Cost of Revenue | 1980.00 | 1266.00 |
| Gross Profit | -1980.00 | -1266.00 |
| Operating Expenses | 7.63 Million | 2.7 Million |
| Selling, General and Administrative Expenses | 3.54 Million | 2.3 Million |
| Research and Development Expenses | 4.08 Million | 392.85 Thousand |
| Other Expenses | - | - |
| Cost and Expenses | 7.63 Million | 2.7 Million |
| Operating Income | -7.63 Million | -2.7 Million |
| Interest Expense | 17.1 Thousand | 107.1 Thousand |
| Income Tax Expense | - | 4.00 |
| Earnings before Tax | -8.35 Million | -6.71 Million |
| Net Income | -8.35 Million | -6.71 Million |
| Earnings Per Share Basic | -0.62 | -8.66 |
| Earnings Per Share Diluted | -0.62 | -8.66 |
| Weighted Average Shares Outstanding | 13.49 Million | 775.63 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 13.49 Million | 775.63 Thousand |
| Gross Margin | - | - |
| EBIT Margin | - | - |
| Profit Margin | - | - |
| EBITDA | -8.33 Million | -6.6 Million |
| Earnings Before Tax Margin | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 2768.00 | - | - |
| Cost of Revenue | 470.00 | 597.00 | 1980.00 | 597.00 | 597.00 | 597.00 |
| Gross Profit | -470.00 | -597.00 | -1980.00 | 2171.00 | -597.00 | -597.00 |
| Operating Expenses | 2.46 Million | 1.75 Million | 7.63 Million | 1.26 Million | 1.14 Million | 1.02 Million |
| Selling, General and Administrative Expenses | 1.21 Million | 1.12 Million | - | 902.1 Thousand | 898.05 Thousand | 784.62 Thousand |
| Research and Development Expenses | 1.25 Million | 629.02 Thousand | - | 361.12 Thousand | 243.94 Thousand | 240.95 Thousand |
| Other Expenses | 470.00 | 597.00 | 1980.00 | 596.00 | 597.00 | 597.00 |
| Cost and Expenses | 2.46 Million | 1.75 Million | 7.63 Million | 1.26 Million | 1.14 Million | 1.02 Million |
| Operating Income | -2.46 Million | -1.75 Million | -7.63 Million | -1.26 Million | -1.14 Million | -1.02 Million |
| Interest Expense | - | - | 17.1 Thousand | -13.56 Thousand | - | - |
| Income Tax Expense | - | 3.00 | -165.91 Thousand | 3.00 | 106.14 Thousand | 23.17 Thousand |
| Earnings before Tax | -2.39 Million | -1.66 Million | -8.35 Million | -1.14 Million | -1.03 Million | -1 Million |
| Net Income | -2.39 Million | -1.66 Million | -8.35 Million | -1.14 Million | -1.03 Million | -1 Million |
| Earnings Per Share Basic | -2.24 | -1.55 | - | -1.32 | -1.19 | -1.28 |
| Earnings Per Share Diluted | -2.24 | -1.55 | - | -1.32 | -1.19 | -1.28 |
| Weighted Average Shares Outstanding | 1.06 Million | 1.07 Million | 868.18 Thousand | 868.18 Thousand | 868.18 Thousand | 781.52 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.06 Million | 1.07 Million | 868.18 Thousand | 868.18 Thousand | 868.18 Thousand | 781.52 Thousand |
| Gross Margin | - | - | - | 0.78 | - | - |
| EBIT Margin | - | - | - | -456.37 | - | - |
| Profit Margin | - | - | - | -413.32 | - | - |
| EBITDA | -2.46 Million | -1.75 Million | - | -1.26 Million | -1.03 Million | -1 Million |
| Earnings Before Tax Margin | - | - | - | -456.59 | - | - |
CUMMINSIND
INDSWFTLTD
KST
300960
SPKSJF
0RH1